Next Article in Journal
Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
Next Article in Special Issue
Previous Vaccination History and Psychological Factors as Significant Predictors of Willingness to Receive Mpox Vaccination and a Favorable Attitude towards Compulsory Vaccination
Previous Article in Journal
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination
Previous Article in Special Issue
Psychological Antecedents of Healthcare Workers towards Monkeypox Vaccination in Nigeria
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 11
Issue 2
10.3390/vaccines11020416
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Associations between Influenza Vaccination and Health Care Access among Adults in the United States

by
Morgan Gurel-Headley
1,2,
Mariam Mamisashvili
3,
Sheena CarlLee
4,
Sharon Reece
4,
Christina Chapman
4,
Shashank Kraleti
1,
Jennifer A. Andersen
5,
James P. Selig
6,
Don E. Willis
5,
Ji Li
6 and
Pearl A. McElfish
5,*
1
College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72205, USA
2
Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72205, USA
3
American MD Program, Faculty of Medicine, Tbilisi State Medical University, 33 Vazha Pshavela Ave., 0162 Tbilisi, Georgia
4
College of Medicine, University of Arkansas for Medical Sciences Northwest, 1125 N. College Ave., Fayetteville, AR 72703, USA
5
College of Medicine, University of Arkansas for Medical Sciences Northwest, 2708 S. 48th St., Springdale, AR 72762, USA
6
Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences Northwest, 2708 S. 48th St., Springdale, AR 72762, USA
*
Author to whom correspondence should be addressed.
Vaccines 2023, 11(2), 416; https://doi.org/10.3390/vaccines11020416
Submission received: 7 December 2022 / Revised: 18 January 2023 / Accepted: 7 February 2023 / Published: 11 February 2023
(This article belongs to the Special Issue Compulsory Vaccination against COVID-19, Influenza and Monkeypox: Pros and Cons)
Versions Notes

Abstract

:
Few studies have investigated the relationship between influenza vaccination and health care access. Furthermore, despite the well-documented disparities in vaccine coverage for communities of color, few studies have examined how experiences of discrimination may influence vaccine uptake. To fill this gap in the literature, this study examined associations between 5-year influenza vaccination rates and sociodemographic characteristics, health care access, and racial discrimination. Age, race/ethnicity, education, health care coverage, primary care provider, no medical care due to cost, and routine doctor checkups were significant correlates of 5-year influenza vaccination. In contrast to previous studies, discrimination scores were not a significant correlate of regular influenza vaccination. Respondents who reported forgoing care due to cost were less likely to report vaccination every year out of the last 5 years compared to all of the less frequent categories combined, demonstrating a more complex association between sometimes not being able to afford medical care and influenza vaccination. Future research should examine the relationship between influenza vaccination uptake, racial discrimination, and forgone care due to cost to enhance resources and messaging for influenza vaccination uptake.

1. Introduction

The Centers for Disease Control and Prevention (CDC) estimates that the influenza virus infected nearly 40 million people in the United States (US) during the 2019–2020 season, causing 400,000 hospitalizations and over 20,000 deaths [1]. The estimated economic burden of influenza to the US health care system is USD 11.2 billion annually [2]. The influenza vaccine is the most effective form of protection against the virus, its complications, and associated costs [3]. The COVID-19 pandemic has only heightened the importance of influenza vaccination, as health care professionals have expressed concerns about possibilities of a “twindemic” or “tridemic” of respiratory viruses [4].
Although uptake of the vaccine has increased for adults over the past three influenza seasons, only 50.2% of the US adult population was vaccinated during the 2020–2021 season [3]. The existing literature shows that rates of influenza vaccination vary by several sociodemographic factors, including age, gender, race/ethnicity, education, and income. Individuals who are older, are women [5,6,7,8], have a higher level of education [6,7], and have higher income [7] are more likely to get the influenza vaccine [9]. Racial and ethnic disparities in vaccine coverage persist, with communities of color being less likely to receive the influenza vaccine [5,7,9,10,11,12,13,14,15].
Though associations between sociodemographic factors and influenza vaccination uptake have been examined, few studies have investigated the relationship between influenza vaccination and health care access [6,16]. Furthermore, despite the well-documented disparities in vaccine coverage for communities of color, few studies have examined how experiences of discrimination may influence vaccine uptake [17,18,19]. Race is “a system of structuring opportunity and assigning value based on the social interpretation of how one looks” [20,21]. However, medical researchers rarely recognize race as a social, rather than biological, construct [22,23]. In doing so, key mechanisms generating racial health disparities—namely, forms of racism—are overlooked [24]. Racial discrimination is unfair treatment based on one’s perceived race, ethnicity, or skin color and is a form of personally mediated racism [25]. The few studies that have investigated relationships between experiences of racial discrimination and influenza vaccination have been limited by their use of single-item measures focused primarily on medical settings, rather than considering the influence of discrimination across multiple settings [17,18,19]. Despite the limitations of the measures used, these studies have documented associations between influenza vaccination and experiences of racial discrimination [17,18,19]. The first known study to document the association found respondents who experienced discrimination had half the uptake as those with no experiences of discrimination [19]. Subsequent studies supported this finding and found evidence that it may be mediated by higher perceived vaccine risk [17,18].
To fill this gap in the literature, this study undertook the following aims. First, the study examined 5-year influenza vaccination rates among US adults by sociodemographic characteristics (age, gender, education, marital status, and race/ethnicity). Based on prior literature, it was hypothesized that being older, identifying as a woman, being married/cohabiting, and having a higher education would be positively associated with influenza vaccination; minority race/ethnicity was hypothesized to be negatively associated with influenza vaccination. Second, the study examined associations between health care access and influenza vaccination. This study used multiple components of health care access to examine this relationship. It was hypothesized that having health care insurance coverage, having a primary care provider, and having seen a provider for a routine checkup within the past 2 years would be positively associated with influenza vaccination; it was hypothesized that forgone care due to costs would be negatively associated with influenza vaccination. Finally, this study investigated associations between influenza vaccination and respondent-reported experiences of racial discrimination in a range of settings. It was hypothesized that a higher racial discrimination score would be negatively associated with influenza vaccination.

2. Methods

2.1. Procedures

Between 7 September 2021 and 3 October 2021, potential respondents were recruited via email using an online registry of research volunteers across the US. Data were obtained through an online survey available in both English and Spanish. To meet inclusion criteria, respondents had to be aged 18 years or older and currently residing in the US. The following study information was provided to each potential respondent in the recruitment emails: (1) estimated study duration; (2) potential risks and benefits of participation; (3) voluntary nature of participation; and (4) confidential nature of participation and data. Respondents provided consent by agreeing to participate in the survey. Data were obtained from a total of 2022 participants who completed the survey. Study procedures were reviewed and approved by the University of Arkansas for Medical Sciences Institutional Review Board (IRB #263020).
To ensure broad representation, racial and ethnic minority populations, including Asian, Black, Hispanic/Latinx, American Indian or Alaska Native (AIAN), and Native Hawaiian or Pacific Islander (NHPI), were intentionally oversampled. Oversampling allows for disaggregation of data across racial and ethnic groups, which in turn aids in revealing diverse attitudes and lived experiences [26,27]. The data were weighted to represent the US population using the random iterative method [28]; this was done across demographic variables including gender (man, woman, non-binary), race/ethnicity (Asian, Black, Hispanic/Latinx, AIAN, NHPI, and White), and age (18–24, 25–34, 35–44, 45–54, 55–64, 65+).

2.2. Measures

2.2.1. Influenza Vaccine Uptake

The dependent variable was an ordinal measure of 5-year influenza vaccine uptake. Participants responded to the question, “How many years in the past 5 years have you gotten a seasonal flu vaccine?” Response options included “never,” “1–2 years,” “3–4 years,” and “every year."

2.2.2. Sociodemographic Characteristics and Experiences with Discrimination

Age, gender, race/ethnicity, education, marital or cohabitating status, and experiences of discrimination were measured as possible correlates of vaccine uptake. Participants’ reported year of birth was used to calculate age. Gender was reported as either man or woman. Options of non-binary and self-identification were available, but too few participants selected these options (N = 8; 0.4%) to be included in the analysis. As a result, these responses were coded as missing. Participants reported their race/ethnicity, and responses were grouped into: Asian, Black, Hispanic/Latinx, AIAN, NHPI, or White. Participants reported their highest level of school completed, and responses were grouped into: high school degree/graduate equivalency degree (GED) or lower, some college/associate degree, and bachelor’s degree or higher. Participants reported their marital or cohabitating status with responses grouped into two categories: married or cohabitating and unmarried or single. Participants were asked if they had experienced discrimination because of their race, ethnicity, or color in any of the following situations: (1) at school; (2) when being hired for a job; (3) at work; (4) in securing housing; (5) in receiving medical care; (6) at a store or restaurant; (7) when securing credit or applying for a mortgage; (8) on the street/in public; and (9) from police or by the courts. Response options for each situation included (1) never; (2) once; (3) two or three times; and (4) four or more times. Item responses were recoded into values of 0, 1, 2.5, and 5 [29]. Discrimination scores were calculated as the sum of the item scores for each of the nine discrimination situations. This sum score could range from a minimum of 0 to a maximum of 45.

2.2.3. Health Care Access

Health care access was measured using four survey items: (1) “Do you have any kind of health care coverage, including health insurance, prepaid plans, such as HMOs, government plans, such as Medicare, or Indian Health Service?” (Yes/No); (2) “Do you have one person you think of as your personal doctor or health care provider?” (Yes/No); (3) “About how long has it been since you last visited a doctor for a routine checkup?” Response options included: in the past year, in the past 2 years, in the past 5 years, 5 or more years ago, and never; and (4) “Was there a time in the past 12 months when you needed a doctor but could not see one because of the cost?” (Yes/No). Due to potential changes in health care-seeking behaviors due to the COVID-19 pandemic, responses to the doctor visit/routine checkup item were collapsed into two categories: within the past 2 years and more than 2 years ago.

2.3. Statistical Analyses

Data were cleaned and analyzed using SAS 9.4 and RStudio [30]. No duplicate records were detected. Participants with incomplete responses (N = 75; 3.7%) were omitted from the analyses. Health care coverage was the variable most often missing (N = 69). Weights, based on population totals, were used to make the results better represent population results. Weights were computed using the random iterative method across the demographic variables of age (18–24, 25–34, 35–44, 45–54, 55–64, 65+), gender (man, woman, non-binary, and self-described), and race/ethnicity (Asian, Black, Hispanic/Latinx, AIAN, NHPI, and White). A cumulative logit model [31] was used because of the ordinal nature of the 5-year influenza vaccine uptake variable. This model consists of three cumulative logits that map onto three cumulative probabilities for past 5-year vaccination: (1) the probability of vaccination every year, 3–4 years, or 1–2 years vs. never; (2) the probability of vaccination every year or 3–4 years vs. 1–2 years or never; and (3) the probability of vaccination every year vs. 3–4 years, 1–2 years, or never. For correlates meeting the proportional odds assumption, a single coefficient was used for each of the cumulative logits. When the assumption was not met, separate coefficients were estimated for each of the cumulative logits. The model was structured to estimate the probability of more regular influenza vaccination. Using the R package brant [32], a Brant test was conducted to assess the assumption of proportional odds. The assumption of proportional odds was not met for at least one of the independent variables (χ2 = 134.03 with df = 34; p <.0001). The results showed both age (p < 0.0001) and forgone care due to cost (p < 0.0001) violated the proportional odds assumption. Therefore, a partial proportional odds (PPO) regression was used, with separate slopes for each cumulative logit for age and no care due to cost but single slopes for all other correlates.

3. Results

3.1. Descriptives

A total of 2022 individuals completed at least part of the survey. Seventy-five (3.7%) individuals were excluded from the analyses because of one or more missing responses. Table 1 provides weighted estimates of descriptive statistics and unweighted sample sizes for all variables included in the regression model for this study.

3.2. Partial Proportional Odds Cumulative Logistic Regression

Table 2 provides the results of the partial proportional odds regression analysis. Age, race/ethnicity, education, health care coverage, primary care provider, no medical care due to cost, and routine doctor checkups were statistically significant correlates of 5-year influenza vaccination. No statistically significant associations were found between 5-year influenza vaccination and gender, marital status, or experiences of racial discrimination.

3.3. Sociodemographic Correlates

With only one exception, younger respondents (18–29, 30–44, and 45–59) had lower odds of regular influenza vaccination than those aged 60+. The one exception was for the model comparing never vaccinated with 1–2 years or more frequent vaccination, where those aged 18–29 were not significantly different from those aged 60+. Asian participants had 69% higher odds of regular influenza vaccination than White participants (OR = 1.69; CI = 1.24, 2.31). Black participants had 37% lower odds of regular vaccination than White participants (OR = 0.63; CI = 0.49, 0.81), and AIAN participants had 38% lower odds than White participants (OR = 0.62; CI = 0.40, 0.96). Those with some college or an associate degree had 23% lower odds of regular influenza vaccination than participants with a high school diploma, GED, or less (OR = 0.77; CI = 0.62, 0.96).

3.4. Health Care Access Correlates

Participants with health care coverage had 43% higher odds of regular influenza vaccination than those without health care coverage (OR = 1.43; CI = 1.08, 1.89). Those who reported having a primary care provider had 64% higher odds of regular influenza vaccination than those without a primary care provider (OR = 1.64; CI = 1.26, 2.14). Participants who reported having visited a doctor in the last 2 years had over twice the odds of regular influenza vaccination compared to those who had not seen a doctor in the past 2 years (OR = 2.93; CI = 2.26, 3.78). The association between having forgone medical care due to cost and regular influenza vaccination was complex. Participants reporting not seeing a doctor due to cost had higher odds of any influenza vaccination (every year, 3–4 years, or 1–2 years) relative to never receiving an influenza vaccination (OR = 1.58; 1.17, 2.13), but had lower odds of influenza vaccinations every year relative to less regular vaccination (3–4 years, 1–2 years, or never) (OR = 0.65; 0.48, 0.88).

4. Discussion

This study examined the association between sociodemographic factors, health care access, and experiences of discrimination on influenza vaccine uptake. Regarding sociodemographic factors, we hypothesized that those who identify as women, are younger, and have lower educational attainment would be less likely to receive the influenza vaccine. Gender was not a significant factor for receiving the influenza vaccine. Respondents aged 18–59 had lower odds of regular influenza vaccination than those aged 60 and older, with one exception: when comparing never vaccinated vs. all other categories, those aged 18–29 were not significantly different from those aged 60+. This finding is mostly consistent with prior literature that has found older individuals to be more likely to receive the influenza vaccine [3,6,9]. Results regarding education were mixed and somewhat unexpected [6,9]. Those with some college/an associate degree were less likely than those with a high school diploma/GED to receive the influenza vaccine. However, the result for those with a bachelor’s degree or higher was not significant.
Regarding race and ethnicity, Asian respondents were approximately two-thirds more likely to receive the influenza vaccine than White respondents. This is consistent with prior studies demonstrating Asian Americans are more likely to be vaccinated than members of other racial and ethnic groups [33]. Black and AIAN respondents were less likely than White respondents to receive the influenza vaccine. These findings are also congruent with the established literature [34,35,36,37,38]. Although NHPI respondents reported slightly lower vaccination uptake than White respondents, the difference was not statistically significant. A CDC report [39] on health care access and utilization among NHPI found that they were more likely to have received an influenza vaccination in the past year compared to the general US population and that their vaccination coverage was similar to that of Asian Americans.
This study makes a necessary contribution to the literature, as it is one of the few national studies with a large sample of AIAN respondents. Furthermore, it is one of the first studies to have a large number of disaggregated Asian and NHPI respondents. Often, these groups are combined in analyses, which impedes the potential to recognize unique experiences and outcomes. These results further demonstrate the need to disaggregate data on Asian and NHPI individuals [27], as differences were found between Asian and White respondents but not between NHPI and White respondents.
We hypothesized that participants with a primary care provider, a checkup with their doctor within the last 2 years, and health insurance coverage would be more likely to receive the influenza vaccine. We also hypothesized that those who had forgone medical care due to cost would be less likely to receive the influenza vaccine. The results supported both these hypotheses. Respondents with a primary care provider were more likely to receive the influenza vaccine than those without, and those who had health insurance coverage were more likely to receive the influenza vaccine than those who did not. Individuals who had seen a doctor for a checkup within the last 2 years were nearly three times more likely to receive the influenza vaccine than those who had not. These findings align with developing literature demonstrating the value of health care providers in vaccine uptake [6,26,40,41,42].
Results of the relationship with forgone care due to cost were mixed. Individuals who had forgone care due to cost were more likely than those who had not forgone care to receive the influenza vaccine at least once in the last 5 years (every year, 1–2 years, 3–4 years) than not at all. However, respondents who had forgone care were less likely to report vaccination every year out of the last 5 years compared to all of the less frequent categories combined (never, 1–2 years, 3–4 years) [9]. Those who face cost barriers may forgo an influenza vaccination even if the vaccines themselves are free of charge. For example, if an individual has vaccine-related questions or concerns but is unable to afford a visit with their provider, they may be discouraged from receiving the influenza vaccine. These results suggest a more complex association between sometimes not being able to afford medical care and influenza vaccination, such that those forgoing care were less likely to be vaccinated every year but were more likely to be vaccinated at least once in the past 5 years.
We hypothesized that respondents who reported more experiences of racial discrimination would be less likely to receive the influenza vaccine; however, racial discrimination was not a significant correlate of regular influenza vaccination. These findings contrast with some reports in the literature that found negative associations between experiences of discrimination and influenza vaccination [18,19]. Discrepancies between our findings and past research may be due to differences in measurement or other analytical decisions. For example, both prior studies used measures of discrimination specific to medical/health care settings [18,19], while we employed a standard multi-item measure of discrimination across many settings [29]. Given that prior studies that found a relationship utilized measures of discrimination specific to medical and health care settings, it may be that our broader measure of racial discrimination is less salient for influenza vaccination than those that are health care-specific. Further, Quinn and colleagues [18] limited their analysis to White and African American respondents in the US, while we examined the association across many racial and ethnic groups. The measure we utilized may not capture experiences of discrimination that are more common among this more diverse sample. For example, it does not include discrimination based on language or accent [43,44].
Although we did not find a significant association between influenza vaccination and this particular form of personally mediated racism, internalized or structural racism may be more salient for vaccine uptake, as some research has demonstrated for COVID-19 vaccination [45]. Importantly, failure to meet the threshold for statistical significance should not be interpreted to mean no relationship exists—we simply did not find evidence for a relationship in these data. To improve health disparities related to vaccination, it is critical to study the impact of all forms of racism on vaccination rates. Our study is one step in this necessary investigation. Future research should continue to examine the role that racism at varying levels may play in shaping influenza vaccination.

Limitations

The results reported should be considered with some limitations in mind. The data are cross-sectional, and our analyses, in turn, could not establish temporal order or causal relationships. Although we drew on a large national sample and utilized weights, our sampling methods were not random. The non-probability sample further limits the generalizability of this study. Online surveys provide many advantages; however, they often suffer from low participation among minoritized racial and ethnic groups and those with lower educational attainment. In anticipation of this, we did correct by oversampling minoritized racial and ethnic groups to ensure representation and allow for disaggregation. Further, we relied on self-reported measures of items, and our outcome measure relied on the recall of respondents to remember past vaccination behaviors over the past 5 years. The time frame in which the study was conducted may have also influenced the results. During the fall of 2021, there were concurrent influenza and COVID-19 vaccination efforts that may have influenced influenza vaccine uptake [46]. Finally, although self-reported experiences of discrimination have been found to be associated with a wide range of health outcomes and behaviors, those experiences may be less salient for vaccination uptake than structural racism, which we did not account for in this analysis.

Author Contributions

M.G.-H.: Writing—original draft; M.M.: Writing—review and editing; S.C.: Writing—review and editing; S.R.: Writing—review and editing; C.C.: Writing—review and editing; S.K.: Writing—review and editing; J.A.A.: Writing—review and editing; J.P.S.: Formal analysis, Writing—original draft, Writing—review and editing; D.E.W.: Conceptualization: Data curation; Methodology, Project administration, Writing—review and editing; J.L.: Formal analysis: Visualization, Writing—original draft, Writing—review and editing; P.A.M.: Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing—original draft, Writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by Reach Out and Connect (ROaC) Program Supplemental funds for Immunization Outreach (6 NU58DP006595-03-01) and Community Engagement Alliance (CEAL) Against COVID-19 Disparities (NIH 10T2HL156812-01). Research was also supported by University of Arkansas for Medical Sciences Translational Research Institute funding awarded through the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR003107).

Institutional Review Board Statement

Study procedures were reviewed and approved by the University of Arkansas for Medical Sciences Institutional Review Board (IRB #263020).

Informed Consent Statement

Respondents provided consent by agreeing to participate in the survey.

Data Availability Statement

The deidentified data underlying the results presented in this study may be made available upon request from the corresponding author, Dr. Pearl A. McElfish, at [email protected]. The data are not publicly available in accordance with funding requirements and participant privacy.

Conflicts of Interest

Dr. Sheena CarlLee reports owning some Pfizer stock. All other authors declared no conflicts of interest.

References

  1. Centers for Disease Control and Prevention. Estimated Influenza Illnesses, Medical visits, and Hospitalizations Averted by Vaccination in the United States—2019–2020 Influenza Season. Available online: https://www.cdc.gov/flu/about/burden-averted/2019-2020.htm (accessed on 25 October 2022).
  2. Putri, W.; Muscatello, D.J.; Stockwell, M.S.; Newall, A.T. Economic burden of seasonal influenza in the United States. Vaccine 2018, 36, 3960–3966. [Google Scholar] [CrossRef] [PubMed]
  3. Centers for Disease Control and Prevention. Flu Vaccination Coverage, United States, 2020–2021 Influenza Season. Available online: https://www.cdc.gov/flu/fluvaxview/coverage-2021estimates.htm (accessed on 1 April 2022).
  4. Suran, M. Preparing Hospitals’ Medical Oxygen Delivery Systems for a Respiratory “Twindemic”. JAMA 2022, 327, 411–413. [Google Scholar] [CrossRef] [PubMed]
  5. Applewhite, A.; Stancampiano, F.F.; Harris, D.M.; Manaois, A.; Dimuna, J.; Glenn, J.; Heckman, M.G.; Brushaber, D.E.; Sher, T.; Valery, J.R. A Retrospective Analysis of Gender-Based Difference in Adherence to Influenza Vaccination during the 2018-2019 Season. J. Prim. Care Community Health 2020, 11, 2150132720958532. [Google Scholar] [CrossRef]
  6. McElfish, P.; Selig, J.; Scott, A.; Rowland, B.; Willis, D.; Reece, S.; CarlLee, S.; Gurel-Headley, M.; Shah, S.; Macechko, M. Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans. Vaccine 2022, 40, 3727–3731. [Google Scholar] [CrossRef] [PubMed]
  7. Li, K.; Yu, T.; Seabury, S.; Dor, A. Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic. Vaccine 2022, 40, 2696–2704. [Google Scholar] [CrossRef] [PubMed]
  8. Vaidya, V.; Partha, G.; Karmakar, M. Gender differences in utilization of preventive care services in the United States. J. Womens Health 2012, 21, 140–145. [Google Scholar] [CrossRef]
  9. Abbas, K.M.; Kang, G.J.; Chen, D.; Werre, S.R.; Marathe, A. Demographics, perceptions, and socioeconomic factors affecting influenza vaccination among adults in the United States. PeerJ 2018, 6, e5171. [Google Scholar] [CrossRef]
  10. Bennett, K.J.; Pumkam, C.; Probst, J.C. Rural-urban differences in the location of influenza vaccine administration. Vaccine 2011, 29, 5970–5977. [Google Scholar] [CrossRef] [PubMed]
  11. Okoli, G.; Abou-Setta, A.; Neilson, C.; Chit, A.; Thommes, E.; Mahmud, S. Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis. Gerontol. Geriatr. Med. 2019, 5, 2333721419870345. [Google Scholar] [CrossRef]
  12. Almario, C.; May, F.; Maxwell, A.; Ren, W.; Ponce, N.; Spiegel, B. Persistent racial and ethnic disparities in flu vaccination coverage: Results from a population-based study. Am. J. Infect. Control 2016, 44, 1004–1009. [Google Scholar] [CrossRef]
  13. Granade, C.; Lindley, M.; Jatlaoui, T.; Asif, A.; Jones-Jack, N. Racial and Ethnic Disparities in Adult Vaccination: A Review of the State of Evidence. Health Equity 2022, 6, 206–223. [Google Scholar] [CrossRef] [PubMed]
  14. Sundaram, M.; Pamplin, J., 2nd. Racial disparities in influenza vaccination. Lancet Healthy Longev. 2021, 2, e115–e116. [Google Scholar] [CrossRef]
  15. Grandhi, G.; Mszar, R.; Vahidy, F.; Valero-Elizondo, J.; Blankstein, R.; Blaha, M.; Virani, S.; Andrieni, J.; Omer, S.; Nasir, K. Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States. JAMA Cardiol. 2021, 6, 87–91. [Google Scholar] [CrossRef] [PubMed]
  16. Logan, J. Disparities in influenza immunization among US adults. J. Natl. Med. Assoc. 2009, 101, 161–166. [Google Scholar] [CrossRef]
  17. Quinn, S.C.; Jamison, A.; An, J.; Freimuth, V.S.; Hancock, G.R.; Musa, D. Breaking down the monolith: Understanding flu vaccine uptake among African Americans. SSM Popul. Health 2018, 4, 25–36. [Google Scholar] [CrossRef]
  18. Quinn, S.C.; Jamison, A.; Freimuth, V.S.; An, J.; Hancock, G.R.; Musa, D. Exploring racial influences on flu vaccine attitudes and behavior: Results of a national survey of White and African American adults. Vaccine 2017, 35, 1167–1174. [Google Scholar] [CrossRef]
  19. Bleser, W.; Miranda, P.; Jean-Jacques, M. Racial/ethnic disparities in influenza vaccination of chronically-ill U.S. adults: The mediating role of perceived discrimination in healthcare. Med. Care 2016, 54, 570–577. [Google Scholar] [CrossRef]
  20. Jones, C. Confronting Institutionalized Racism. Phylon 2002, 50, 7–22. [Google Scholar] [CrossRef]
  21. Jones, C.; Truman, B.; Elam-Evans, L.; Jones, C.; Jones, C.; Jiles, R.; Rumisha, S.; Perry, G. Using “socially assigned race” to probe white advantages in health status. Ethn. Dis. 2008, 18, 496–504. [Google Scholar] [PubMed]
  22. Williams, D. Race and health: Basic questions, emerging directions. Ann. Epidemiol. 1997, 7, 322–333. [Google Scholar] [CrossRef]
  23. Martinez, R.; Andrabi, N.; Goodwin, A.; Wilbur, R.; Smith, N.; Zivich, P. Conceptualization, Operationalization, and Utilization of Race and Ethnicity in Major Epidemiology Journals 1995-2018: A Systematic Review. Am. J. Epidemiol. 2022, kwac146. [Google Scholar] [CrossRef]
  24. Phelan, J.; Link, B. Is Racism a Fundamental Cause of Inequalities in Health? Annu. Rev. Sociol. 2015, 41, 311–330. [Google Scholar] [CrossRef]
  25. Jones, C. Levels of racism: A theoretic framework and a gardener’s tale. Am. J. Public Health 2000, 90, 1212–1215. [Google Scholar] [CrossRef]
  26. Chang, R.; Penaia, C.; Thomas, K. Count Native Hawaiian And Pacific Islanders in COVID-19 Data-It’s An OMB Mandate. In Health Affairs Blog; HealthAffairs: Washington, DC, USA, 2020. [Google Scholar]
  27. Gee, G.; Morey, B.; Bacong, A.; Doan, T.; Penaia, C. Considerations of Racism and Data Equity Among Asian Americans, Native Hawaiians, And Pacific Islanders in the Context of COVID-19. Curr. Epidemiol. Rep. 2022, 9, 77–86. [Google Scholar] [CrossRef]
  28. Mercer, A.; Lau, A.; Kennedy, C. How Different Weighting Methods Work; Pew Research Center Methods: Washington, DC, USA, 2018. [Google Scholar]
  29. Krieger, N.; Smith, K.; Naishadham, D.; Hartman, C.; Barbeau, E. Experiences of discrimination: Validity and reliability of a self-report measure for population health research on racism and health. Soc. Sci. Med. 2005, 61, 1576–1596. [Google Scholar] [CrossRef]
  30. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Australia, 2022. [Google Scholar]
  31. Agresti, A. Categorical Data Analysis, 2nd ed.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2002. [Google Scholar]
  32. Schlegel, B.; Steenbergen, M. Brant: Test for Parallel Regression Assumption. R Package Version 0.3-0. 2020. Available online: https://cran.r-project.org/web/packages/brant/brant.pdf (accessed on 18 January 2023).
  33. Linn, S.; Guralnik, J.; Patel, K. Disparities in influenza vaccine coverage in the United States, 2008. J. Am. Geriatr. Soc. 2010, 58, 1333–1340. [Google Scholar] [CrossRef] [PubMed]
  34. Lu, P.J.; Singleton, J.A.; Euler, G.L.; Williams, W.W.; Bridges, C.B. Seasonal influenza vaccination coverage among adult populations in the United States, 2005-2011. Am. J. Epidemiol. 2013, 178, 1478–1487. [Google Scholar] [CrossRef] [PubMed]
  35. Lu, P.J.; Hung, M.C.; O’Halloran, A.C.; Ding, H.; Srivastav, A.; Williams, W.W.; Singleton, J.A. Seasonal Influenza Vaccination Coverage Trends Among Adult Populations, United States, 2010–2016. Am. J. Prev. Med. 2019, 57, 458–469. [Google Scholar] [CrossRef]
  36. Lu, P.J.; O’Halloran, A.; Bryan, L.; Kennedy, E.D.; Ding, H.; Graitcer, S.B.; Santibanez, T.A.; Meghani, A.; Singleton, J.A. Trends in racial/ethnic disparities in influenza vaccination coverage among adults during the 2007–2008 through 2011–2012 seasons. Am. J. Infect. Control 2014, 42, 763–769. [Google Scholar] [CrossRef] [PubMed]
  37. Lu, P.J.; Hung, M.C.; Srivastav, A.; Grohskopf, L.A.; Kobayashi, M.; Harris, A.M.; Dooling, K.L.; Markowitz, L.E.; Rodriguez-Lainz, A.; Williams, W.W. Surveillance of Vaccination Coverage Among Adult Populations-United States, 2018. MMW Surveill. Summ. 2021, 70, 1–26. [Google Scholar] [CrossRef] [PubMed]
  38. Srivastav, A.; O’Halloran, A.; Lu, P.; Williams, W. Influenza Vaccination Coverage Among English-Speaking Asian Americans. Am. J. Prev. Med. 2018, 55, e123–e137. [Google Scholar] [CrossRef] [PubMed]
  39. Zelaya, C.; Galinsky, A.; Simile, C.; Barnes, P. Health Care Access and Utilization among Native Hawaiian and Pacific Islander Persons in the United States, 2014. Vital Health Stat. 2017, 41, 1–79. [Google Scholar]
  40. Winston, C.A.; Wortley, P.M.; Lees, K.A. Factors associated with vaccination of medicare beneficiaries in five U.S. communities: Results from the racial and ethnic adult disparities in immunization initiative survey, 2003. J. Am. Geriatr. Soc. 2006, 54, 303–310. [Google Scholar] [CrossRef]
  41. Bhanu, C.; Gopal, D.P.; Walters, K.; Chaudhry, U.A.R. Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review. PLoS Med. 2021, 18, e1003826. [Google Scholar] [CrossRef] [PubMed]
  42. National Adult and Influenza Immunization Summit. Call to Action to Protect All Adults from Vaccine-Preventable Disease and Disability; National Adult and Influenza Immunization Summit: Saint Paul, Minnesota, 2021. [Google Scholar]
  43. Gee, G.; Ro, A.; Shariff-Marco, S.; Chae, D. Racial Discrimination and Health Among Asian Americans: Evidence, Assessment, and Directions for Future Research. Epidemiol. Rev. 2009, 31, 130–151. [Google Scholar] [CrossRef] [PubMed]
  44. Shariff-Marco, S.; Breen, N.; Landrine, H.; Reeve, B.; Krieger, N.; Gee, G.; Williams, D.; Mays, V.; Ponce, N.; Alegría, M.; et al. MEASURING EVERYDAY RACIAL/ETHNIC DISCRIMINATION IN HEALTH SURVEYS: How Best to Ask the Questions, in One or Two Stages, Across Multiple Racial/Ethnic Groups? Du Bois Rev. 2011, 8, 159–177. [Google Scholar] [CrossRef] [PubMed]
  45. Siegel, M.; Critchfield-Jain, I.; Boykin, M.; Owens, A.; Muratore, R.; Nunn, T.; Oh, J. Racial/Ethnic Disparities in State-Level COVID-19 Vaccination Rates and Their Association with Structural Racism. J. Racial Ethn. Health Disparities 2021, 9, 2361–2374. [Google Scholar] [CrossRef]
  46. Kuehn, B. Influenza Vaccination Increased During the COVID-19 Pandemic. JAMA 2021, 326, 2465. [Google Scholar] [CrossRef] [PubMed]
Table
Table 1. Weighted and Unweighted Descriptive Statistics for All Study Variables (N = 1947).
Table 1. Weighted and Unweighted Descriptive Statistics for All Study Variables (N = 1947).
MeasuresWeighted % or Mean (SD)Unweighted N
Age (N = 2022)
18–2918.9360
30–4427.0716
45–5923.7495
60+30.3451
Gender (N = 2014)
Man50.0952
Woman50.01062
Race/Ethnicity (N = 2022)
Asian10.0304
Black20.0404
Hispanic/Latinx20.0404
AIAN5.0254
NHPI5.0252
White40.0404
Education (N = 2022)
HS degree/GED or lower28.2581
Some college/associate degree34.0692
Bachelor’s degree or higher37.8749
Marital Status (N = 2022)
Married/cohabitating47.6976
Unmarried/single52.41046
Health Care Coverage (N = 1953)
Yes86.91675
No13.1278
Primary Care Provider (N = 2022)
Yes81.31594
No18.7428
No Medical Care Due to Cost (N = 2022)
No83.41634
Yes16.6388
Routine Doctor Checkup (N = 2022)
Within the past 2 years81.31624
More than 2 years ago18.8398
5-Year Influenza Vaccination (N = 2022)
Never29.5619
1–2 years22.3489
3–4 years10.3209
Every year37.9705
Discrimination Score (N = 2022)6.4 (9.8)
Note: Percentages may not total 100 due to rounding. AIAN = American Indian or Alaska Native; GED = graduate equivalency degree; HS = high school; NHPI = Native Hawaiian or Pacific Islander; SD = standard deviation.
Table
Table 2. Weighted Proportional Ordinal Logistic Regression—5-Year Influenza Vaccination (N = 1947).
Table 2. Weighted Proportional Ordinal Logistic Regression—5-Year Influenza Vaccination (N = 1947).
BSEpOR (95% CI)
AgeEvery Year vs. All Others
18–29−0.8820.169<0.001 0.414 (0.298, 0.576)
30–44−1.1430.141<0.001 0.319 (0.242, 0.420)
45–59−0.6730.132<0.001 0.510 (0.394, 0.661)
60+----
Every Year and 3–4 Years vs. All Others
18–29−0.9060.163<0.001 0.404 (0.293, 0.557)
30–44−1.1090.137<0.001 0.330 (0.252, 0.432)
45–59−0.8080.134<0.001 0.446 (0.343, 0.579)
60+----
Every Year, 3–4 Years, and 1–2 Years vs. Never
18–290.0450.1780.803 1.045 (0.738, 1.482)
30–44−0.5790.147<0.001 0.560 (0.420, 0.747)
45–59−0.5210.147<0.001 0.594 (0.445, 0.792)
60+----
Gender
Woman−0.1600.0880.069 0.852 (0.716, 1.013)
Man----
Race/Ethnicity
Asian0.5250.159<0.001 1.690 (1.238, 2.306)
Black−0.4690.129<0.001 0.626 (0.486, 0.806)
Hispanic/Latinx−0.1210.1230.326 0.886 (0.697, 1.127)
AIAN−0.4790.2210.030 0.619 (0.401, 0.955)
NHPI−0.0380.2140.858 0.962 (0.633, 1.464)
White----
Education
Bachelor’s degree or higher−0.1000.1140.382 0.905 (0.723, 1.132)
Some college/associate degree−0.2620.1120.020 0.769 (0.617, 0.959)
HS diploma/GED or lower----
Marital Status
Married/cohabitating0.0390.0910.671 1.039 (0.870, 1.241)
Unmarried/single----
Health Care Coverage
Yes0.3570.1410.011 1.429 (1.084, 1.885)
No----
Primary Care Provider
Yes0.4930.136<0.001 1.637 (1.255, 2.135)
No----
No Medical Care Due to CostEvery Year vs. All Others
Yes−0.4270.1530.005 0.653 (0.484, 0.880)
No----
Every Year and 3–4 Years vs. All Others
Yes−0.1940.1390.163 0.823 (0.627, 1.082)
No----
Every Year, 3–4 Years, and 1–2 Years vs. Never
Yes0.4550.1530.003 1.576 (1.168, 2.125)
No----
Routine Doctor Checkup
Within the past 2 years1.0740.131<0.001 2.926 (2.263, 3.783)
More than 2 years ago----
Discrimination Score0.0060.0050.190 1.006 (0.997, 1.016)
Note: Significant p-values are in bold. AIAN = American Indian or Alaska Native; Β = beta; CI = confidence interval; GED = graduate equivalency degree; HS = high school; NHPI = Native Hawaiian or Pacific Islander; OR = odds ratio; SE = standard error.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gurel-Headley, M.; Mamisashvili, M.; CarlLee, S.; Reece, S.; Chapman, C.; Kraleti, S.; Andersen, J.A.; Selig, J.P.; Willis, D.E.; Li, J.; et al. Associations between Influenza Vaccination and Health Care Access among Adults in the United States. Vaccines 2023, 11, 416. https://doi.org/10.3390/vaccines11020416

AMA Style

Gurel-Headley M, Mamisashvili M, CarlLee S, Reece S, Chapman C, Kraleti S, Andersen JA, Selig JP, Willis DE, Li J, et al. Associations between Influenza Vaccination and Health Care Access among Adults in the United States. Vaccines. 2023; 11(2):416. https://doi.org/10.3390/vaccines11020416

Chicago/Turabian Style

Gurel-Headley, Morgan, Mariam Mamisashvili, Sheena CarlLee, Sharon Reece, Christina Chapman, Shashank Kraleti, Jennifer A. Andersen, James P. Selig, Don E. Willis, Ji Li, and et al. 2023. "Associations between Influenza Vaccination and Health Care Access among Adults in the United States" Vaccines 11, no. 2: 416. https://doi.org/10.3390/vaccines11020416

APA Style

Gurel-Headley, M., Mamisashvili, M., CarlLee, S., Reece, S., Chapman, C., Kraleti, S., Andersen, J. A., Selig, J. P., Willis, D. E., Li, J., & McElfish, P. A. (2023). Associations between Influenza Vaccination and Health Care Access among Adults in the United States. Vaccines, 11(2), 416. https://doi.org/10.3390/vaccines11020416

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop